You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumour cell mobilization

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Efficacy Trial in Suzhou (TAB008, Bevacizumab)

Completed
  • Efficacy
  • Suzhou, Jiangsu, China
    TOT
Jun 16, 2022

Sarcoma Trial in Baltimore (biological, drug, procedure, radiation)

Completed
Has Results
  • Sarcoma
  • filgrastim
  • +4 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 5, 2020

Pediatric Obesity, COVID-19 Trial in Al Kharj (High-intensity aerobic training with high protein diet, Control group)

Completed
  • Pediatric Obesity
  • COVID-19
  • High-intensity aerobic training with high protein diet
  • Control group
  • Al Kharj, Riyadh, Saudi Arabia
    Gopal Nambi
Apr 20, 2022

Hepatic Impairment and Myelosuppression in Breast Cancer

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jun 11, 2023

    Interstitial Cystitis Trial (Interferon, Sodium Hyaluronate, Sodium Chloride Injection)

    Not yet recruiting
    • Interstitial Cystitis
    • (no location specified)
    Jun 10, 2023

    PTCL Trial in Long Beach, New Haven, Charlottesville (Azacytidine, Romidepsin, Belinostat)

    Recruiting
    • PTCL
    • Long Beach, California
    • +2 more
    Mar 1, 2022

    Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

    Completed
    Has Results
    • Metastatic Carcinoma in the Liver
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Feb 25, 2022

    CNS Lymphoma Trial in Seongnam-si (lenalidomide)

    Recruiting
    • Central Nervous System Lymphoma
    • Seongnam-si, Please Select, Korea, Republic of
      Seoul National University Bundang Hospital
    Feb 18, 2022

    HIV Nephropathy, Kidney Injury, Kidney Diseases Trial in London

    Active, not recruiting
    • HIV Nephropathy
    • +6 more
      • London, United Kingdom
        King's College Hospital NHS Foundation Trust
      Jan 5, 2023

      Peripheral T-Cell Lymphoma Trial in Worldwide (SP-02L (darinaparsin for injection))

      Completed
      • Peripheral T-Cell Lymphoma
      • SP-02L (darinaparsin for injection)
      • Hong Kong, Hong Kong
      • +23 more
      Jul 22, 2021

      AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

      Not yet recruiting
      • AL Amyloidosis
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Aug 16, 2022

      Small Cell Lung Cancer Trial in Italy (Etoposide, Carboplatin, Bevacizumab)

      Active, not recruiting
      • Small Cell Lung Cancer
      • Bologna, Italy
      • +14 more
      Sep 7, 2022

      Interaction Between Benralizumab and Basophils in Eosinophilic

      Not yet recruiting
      • Asthma; Eosinophilic
      • BENRALIZUMAB
      • (no location specified)
      Aug 25, 2021

      Lung Transplant Reject, Bronchiolitis Obliterans Trial in Jacksonville (Mesenchymal stem cell 0.5, Mesenchymal stem cell 1.0)

      Completed
      • Lung Transplant Reject
      • Bronchiolitis Obliterans
      • Mesenchymal stem cell 0.5
      • Mesenchymal stem cell 1.0
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Oct 5, 2021

      Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

      Recruiting
      • Relapsed Refractory Multiple Myeloma
      • Abemaciclib, dexamethasone, ixazomib, pomalidomide
      • +7 more
      • Phoenix, Arizona
      • +16 more
      Sep 9, 2021

      Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of

      Recruiting
      • Rheumatoid Arthritis
      • +3 more
        • Barcelona, Spain
          Hospital de la Santa Creu i Sant Pau
        Apr 25, 2022

        Esophagus SCC Trial in Jinan (Sintilimab Injection plus Paclitaxel and Cisplatin, Paclitaxel and Cisplatin)

        Withdrawn
        • Esophagus SCC
        • Sintilimab Injection plus Paclitaxel and Cisplatin
        • Paclitaxel and Cisplatin
        • Jinan, Shandong, China
          Qilu Hospital of Shandong University
        Apr 19, 2022

        Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in Houston

        Active, not recruiting
        • Malignant Solid Neoplasm
        • +2 more
        • 3-Dimensional Conformal Radiation Therapy
        • +6 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jul 18, 2022

        Biliary Tract Cancer Trial in Seoul ('SMT-NK' Inj (allogeneic Natural Killer cell), Pembrolizumab Injection [Keytruda])

        Completed
        • Biliary Tract Cancer
        • 'SMT-NK' Inj (allogeneic Natural Killer cell)
        • Pembrolizumab Injection [Keytruda]
        • Seoul, Korea, Republic of
        • +1 more
        Mar 28, 2022

        SCLC, Recurrent Trial in Seoul (Durvalumab+AZD2811 to SCLC patients)

        Terminated
        • SCLC, Recurrent
        • Durvalumab+AZD2811 to SCLC patients
        • Seoul, Gangnam-gu, Korea, Republic of
          Samsung Medical Center
        Feb 8, 2022

        HIV Trial in Canada, United States (Indinavir sulfate, Ritonavir, Nelfinavir mesylate)

        Completed
        • HIV Infections
        • Indinavir sulfate
        • +2 more
        • San Francisco, California
        • +43 more
        Oct 27, 2021

        Esophageal Squamous Cell Carcinoma Trial in Shanghai (Paclitaxel, Carboplatin, Radiotherapy)

        Active, not recruiting
        • Esophageal Squamous Cell Carcinoma
        • Shanghai, Shanghai, China
          Fudan Universtiy Shanghai Cancer Center
        Jul 6, 2021

        Stargardt's Macular Dystrophy Trial in Los Angeles, Miami, Philadelphia (MA09-hRPE)

        Completed
        • Stargardt's Macular Dystrophy
        • MA09-hRPE
        • Los Angeles, California
        • +2 more
        Jul 4, 2021

        Large B-cell Lymphoma Trial in Houston (Prednisone, Rituximab, Cyclophosphamide)

        Not yet recruiting
        • Large B-cell Lymphoma
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 19, 2023

        Bariatric Surgery Trial in Hvidovre (Placebo, GLP-1 antagonism, GIP antagonism)

        Completed
        • Bariatric Surgery
        • Placebo
        • +3 more
        • Hvidovre, Denmark
        • +1 more
        Jan 31, 2022